Emtricitabine / Tenofovir Disoproxil Uses, Dosage, Side Effects and Interactions
Truvada
Truvada was the first emtricitabine / tenofovir disoproxil product the FDA approved, in August 2004. An FDA-approved generic with the same active ingredients is listed.
Emtricitabine/TDF
Emtricitabine/TDF is a brand of emtricitabine / tenofovir disoproxil that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.
Emtricitabine / tenofovir disoproxil is a two-drug HIV medicine used to treat HIV-1 infection (with other HIV medicines) and, in adults at high risk, to help prevent sexually acquired HIV-1.
Quick links
Ask Anything About Emtricitabine / Tenofovir DisoproxilType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Emtricitabine / Tenofovir Disoproxil in Short
- Drug class HIV Nucleoside Analog Reverse Transcriptase Inhibitor How the FDA classifies it
What it treatsThis combination treats HIV-1 infection in adults and children weighing at least 17 kg. It is always used together with other HIV medicines. The Truvada brand is also approved for pre-exposure prophylaxis (PrEP). PrEP lowers the risk of getting HIV-1 through sex in adults at high risk.
- How you get it Prescription only
- Comes asTablet (by mouth)Available strengths (emtricitabine/tenofovir disoproxil)
- 100 mg/150 mg
- 133 mg/200 mg
- 167 mg/250 mg
- 200 mg/300 mg
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$0.51 to $9.36 a tablet
- Truvada (brand)$59.59 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Emtricitabine / tenofovir disoproxil (Truvada), on the market since about 2004 and with FDA-approved generics listed, pairs two drugs that block an enzyme HIV needs to copy itself; it treats HIV-1 alongside other HIV medicines and, as the original PrEP (pre-exposure prophylaxis) medicine, lowers the risk of getting HIV-1 through sex in adults at high risk. Most people tolerate it well; nausea, diarrhea, headache or tiredness are common early and often ease within weeks. Its boxed warning covers rare, possibly fatal lactic acidosis (acid buildup in the blood) with liver enlargement, severe hepatitis B flares after stopping, and drug-resistant HIV if PrEP is started during an undetected infection.
Key Takeaways From the HelloPharmacist Team
- Take one tablet once a day, with or without food, and do not skip doses, since PrEP protects best when taken every day.
- Expect hepatitis B testing first, regular blood and urine kidney checks, and on PrEP an HIV test about every 3 months.
- Never stop it on your own, especially if you have hepatitis B, because stopping can set off a severe liver flare.
- Avoid regular or combined use of NSAID pain relievers like ibuprofen and naproxen, which can add strain to your kidneys.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Emtricitabine / Tenofovir Disoproxil.
This medicine carries a boxed warning, the FDA's strongest warning, with three main risks.
- Lactic acidosis and severe liver enlargement with fat buildup: These have been reported, including fatal cases, with this type of drug.
- Hepatitis B flare-ups: It is not approved to treat hepatitis B. People with both HIV-1 and hepatitis B can have severe flares after stopping it. Liver function should be monitored closely for at least several months after stopping, and hepatitis B treatment may be needed.
- Drug resistance with PrEP: Truvada for PrEP must only be given to people confirmed HIV-negative before starting and at least every 3 months. If someone has an undetected early HIV infection, resistant HIV can develop. Do not start PrEP if there are signs of acute HIV infection unless a negative status is confirmed.
Patient Information Guide for Emtricitabine / Tenofovir Disoproxil
What It’s Used For
This combination is used for HIV-1 treatment and, for the Truvada brand, prevention.
- Treatment of HIV-1 infection, together with other antiretroviral medicines, in adults and children weighing at least 17 kg (Truvada).
- Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk, along with safer sex practices (Truvada).
How It Works
The tablet contains two antiviral drugs, emtricitabine and tenofovir disoproxil fumarate. Both are nucleoside analog reverse transcriptase inhibitors. They block an enzyme HIV-1 needs to make copies of itself.
Drug Class
Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor from emtricitabine
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Emtricitabine / Tenofovir Disoproxil has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor from emtricitabine
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Nucleoside Reverse Transcriptase Inhibitors from emtricitabine
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Emtricitabine / Tenofovir Disoproxil in the FDA’s index.
From our Patient Information GuideThe tablet contains two antiviral drugs, emtricitabine and tenofovir disoproxil fumarate. Both are nucleoside analog reverse transcriptase inhibitors. They block an enzyme HIV-1 needs to make copies of itself. Read How Emtricitabine / Tenofovir Disoproxil Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Nucleosides from emtricitabine
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Antivirals for treatment of HIV infections, combinations
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
The tablet is swallowed once a day, with or without food. The regular tablet is for people weighing at least 35 kg, and a low-strength tablet is used for children weighing at least 17 kg.
People with reduced kidney function may need a different schedule or may not be able to take it. Follow your prescriber and the label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Emtricitabine / Tenofovir Disoproxil Emtricitabine Tenofovir Disoproxil Tablets
HIV-1 infection treatment
Adults and children weighing at least 35 kg Usual dose 1 tablet (200 mg FTC and 300 mg TDF) once a day
- One tablet (containing 200 mg of FTC and 300 mg of TDF) once daily taken orally with or without food
TDF stands for tenofovir disoproxil fumarate.
Children weighing 17 to less than 22 kg Usual dose One 100 mg/150 mg tablet once a day
Good to know
Weight should be monitored periodically and dose adjusted
Children weighing 22 to less than 28 kg Usual dose One 133 mg/200 mg tablet once a day
Good to know
Weight should be monitored periodically and dose adjusted
Children weighing 28 to less than 35 kg Usual dose One 167 mg/250 mg tablet once a day
Good to know
Weight should be monitored periodically and dose adjusted
Adults with mild or normal kidney function Every 24 hours
Good to know
Dosing interval adjustment for kidney function
Adults with moderate kidney problems Usual dose 1 tablet every 48 hours
Good to know
Closely monitor response and kidney function
Lowering the risk of getting HIV-1 (PrEP)
For adults and teens weighing at least 35 kg who do not have HIV-1
Usual dose 1 tablet (200 mg FTC and 300 mg TDF) once a day
- One tablet (containing 200 mg of FTC and 300 mg of TDF) once daily taken orally with or without food
Good to know
Not recommended if CrCl is below 60 mL/min
TDF stands for tenofovir disoproxil fumarate.
CrCl means creatinine clearance, a measure of how well the kidneys work.
Emtricitabine / Tenofovir Disoproxil Truvada Tablets
HIV-1 infection treatment
Adults and children weighing 35 kg or more Usual dose 1 tablet (200 mg of emtricitabine emtricitabine and 300 mg of tenofovir tenofovir disoproxil fumarate) once a day
- One tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate) once daily taken orally with or without food
Children weighing 17 to less than 22 kg Usual dose One 100/150 tablet once a day
Good to know
Weight should be monitored periodically
Children weighing 22 to less than 28 kg Usual dose One 133/200 tablet once a day
Good to know
Weight should be monitored periodically
Children weighing 28 to less than 35 kg Usual dose One 167/250 tablet once a day
Good to know
Weight should be monitored periodically
Adults with moderate kidney problems Usual dose 1 tablet every 48 hours
Good to know
Closely monitor response and kidney function
Lowering the risk of getting HIV-1 (PrEP)
For adults who do not have HIV-1
Usual dose 1 tablet (200 mg of emtricitabine emtricitabine and 300 mg of tenofovir tenofovir disoproxil fumarate) once a day
- One tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate) once daily taken orally with or without food
Good to know
Do not use if estimated creatinine clearance is below 60 mL/min
Side Effects
In people with HIV-1, common side effects include:
Common side effects
- Diarrhea
- Nausea
- Fatigue
- Headache
- Dizziness
- Depression
- Trouble sleeping or unusual dreams
- Rash
When to get medical help
- Call your doctor right away if you have signs of lactic acidosis or liver problems. The label warns these can be fatal.
- Tell your doctor if you have hepatitis B and stop or plan to stop this medicine. Hepatitis B can flare up severely.
- Report new or worsening kidney problems, which can include kidney failure and Fanconi syndrome (a kidney tube disorder).
- If you take it for PrEP and develop flu-like or other symptoms of new HIV infection, contact your provider promptly.
- Report signs of immune reconstitution syndrome (the immune system reacting to old infections once HIV is controlled).
- Tell your doctor if you have a bone fracture or bone pain, since this medicine can lower bone density.
In PrEP trials, headache, abdominal pain and weight decrease were more common than with placebo. Skin darkening on the palms or soles was generally mild. Report signs of kidney, liver or bone problems to your doctor.
Warnings and Precautions
- Boxed warning: lactic acidosis with severe liver enlargement, hepatitis B flares after stopping, and drug resistance if used for PrEP during undetected early HIV infection.
- Kidney injury, including kidney failure and Fanconi syndrome. Avoid nephrotoxic drugs.
- Decreased bone mineral density.
- Body fat redistribution and immune reconstitution syndrome.
- Not recommended as part of a triple nucleoside-only regimen, because early treatment failure has been reported.
- PrEP is not always effective, so use it with other prevention measures and take every dose.
Interactions
Several medicines can change drug levels or add kidney strain.
- Other emtricitabine, tenofovir or lamivudine products: do not combine.
- Hepsera (adefovir): do not combine.
- Didanosine: levels rise, raising risk of pancreatitis and neuropathy.
- Atazanavir: levels fall, so it should be given with ritonavir.
- Lopinavir/ritonavir, darunavir/ritonavir and some hepatitis C medicines: tenofovir levels rise.
- Acyclovir, valacyclovir, ganciclovir, aminoglycosides and high-dose or multiple NSAIDs: may raise drug levels and affect the kidneys.
Interactions Listed in the FDA-Approved Label
From the Emtricitabine / Tenofovir Disoproxil prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
DidanosineWhat happensTenofovir disoproxil fumarate increases didanosine concentrations, which could worsen didanosine side effects such as pancreatitis and neuropathy.What to doMonitor closely and discontinue didanosine if reactions develop; in patients weighing greater than 60 kg, reduce didanosine dose to 250 mg; no dose recommendation for those under 60 kg.
-
Atazanavir, lopinavir/ritonavir, atazanavir/ritonavir, darunavir/ritonavir (HIV-1 protease inhibitors)What happensAtazanavir concentrations decrease and tenofovir concentrations increase.What to doGive atazanavir 300 mg with ritonavir 100 mg; monitor for TDF-associated adverse reactions and discontinue the tablets if they develop.
-
Sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir (hepatitis C agents)What happensTenofovir concentrations increase.What to doMonitor for TDF-associated adverse reactions; with HARVONI plus an HIV-1 protease inhibitor/ritonavir or cobicistat, consider an alternative HCV or antiretroviral therapy, or monitor if coadministration is necessary.
-
Drugs eliminated by active tubular secretion (acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides, high-dose or multiple NSAIDs)What happensMay increase concentrations of FTC, tenofovir, and/or the coadministered drug.
-
Drugs that decrease renal functionWhat happensMay increase concentrations of FTC and/or tenofovir.
Read the label’s full interactions text
7 DRUG INTERACTIONS Tenofovir disoproxil fumarate increases didanosine concentrations. Dose reduction and close monitoring for didanosine toxicity are warranted. Coadministration decreases atazanavir concentrations. When coadministered with emtricitabine and tenofovir disoproxil fumarate tablets, use atazanavir given with ritonavir. Coadministration of emtricitabine and tenofovir disoproxil fumarate tablets with certain HIV-1 protease inhibitors or certain drugs to treat HCV increases tenofovir concentrations. Monitor for evidence of tenofovir toxicity. Consult Full Prescribing Information prior to and during treatment for important drug interactions. 7.1 Drugs Affecting Renal Function FTC and tenofovir are primarily excreted by the kidneys by a combination of glomerular filtration and active tubular secretion. No drug-drug interactions due to competition for renal excretion have been observed; however, coadministration of emtricitabine and tenofovir disoproxil fumarate tablets with drugs that are eliminated by active tubular secretion may increase concentrations of FTC, tenofovir, and/or the coadministered drug. Some examples include, but are not limited to, acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs. Drugs that decrease renal function may increase concentrations of FTC and/or tenofovir. 7.2 Established and Significant Interactions Table 7 provides a listing of established or clinically significant drug interactions.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use for PrEP if HIV-1 status is unknown or positive.
- Get tested for hepatitis B before starting.
- Have kidney function and urine tests checked before and during use.
- Kidney impairment can limit use or change the dosing schedule.
- Tell your doctor about fracture history or bone loss risk.
- Pregnancy: observational data show no increased risk of major birth defects, and a pregnancy registry exists.
- Mothers with HIV-1 should not breastfeed.
- Pharmacokinetics have not been fully evaluated in people 65 and older.
Overdose
If an overdose occurs, the person should be monitored for signs of toxicity and given standard supportive care. In small studies, higher-than-usual doses of the individual components did not cause severe reactions. Hemodialysis removes some of each drug.
Half-Life and How Your Body Processes It
Both drugs are absorbed after swallowing. Emtricitabine is well absorbed, with peak levels in 1 to 2 hours, and tenofovir peaks in about 1 hour. Food does not affect emtricitabine and modestly raises tenofovir, so the tablet can be taken with or without food. Both are cleared mainly by the kidneys. The half-life is about 10 hours for emtricitabine and about 17 hours for tenofovir.
Storage
Store at 25 °C (77 °F), excursions permitted to 15 °C–30 °C (59 °F–86 °F) (see USP Controlled Room Temperature).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Emtricitabine / Tenofovir Disoproxil: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Emtricitabine / Tenofovir Disoproxil — the kind of thing our pharmacy team would talk through with you at the counter.
What is this medicine for?
How do I take it?
What side effects should I expect?
Why do I need so many blood and urine tests?
Is it safe to stop if I have hepatitis B?
Can I take it with my other medicines?
Is emtricitabine / tenofovir disoproxil available over the counter?
When was emtricitabine / tenofovir disoproxil first available?
Who makes emtricitabine / tenofovir disoproxil?
What is the brand name of emtricitabine / tenofovir disoproxil?
What is the generic name of Truvada?
What drug class is emtricitabine / tenofovir disoproxil?
Is there a generic version of emtricitabine / tenofovir disoproxil?
What strengths does emtricitabine / tenofovir disoproxil come in?
How much does emtricitabine / tenofovir disoproxil cost?
Where can I read the emtricitabine / tenofovir disoproxil prescribing information (package insert)?
Is emtricitabine / tenofovir disoproxil gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Emtricitabine / Tenofovir Disoproxil
Skip the scrolling. Ask in your own words and get an answer from Emtricitabine / Tenofovir Disoproxil’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Emtricitabine / Tenofovir Disoproxil’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Emtricitabine / Tenofovir Disoproxil on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Emtricitabine / Tenofovir Disoproxil Forms and Strengths (How It Comes)
Emtricitabine / Tenofovir Disoproxil comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Emtricitabine / Tenofovir Disoproxil inactive ingredients by manufacturer.
Tablet
How this form is used
- Truvada is used with other antiretroviral medicines to treat HIV-1 infection in adults and children weighing at least 17 kg.
- Truvada is used with safer sex practices as PrEP to reduce the risk of sexually acquired HIV-1 in adults at high risk.
- Truvada tablets are taken by mouth once daily, with or without food.
- Emtricitabine and Tenofovir Disoproxil Fumarate tablets are taken by mouth once daily, with or without food.
- Truvada low-strength tablets are used for children weighing at least 17 kg, based on body weight.
- For Truvada PrEP, HIV-1 testing is needed before starting and at least every 3 months.
Emtricitabine / Tenofovir Disoproxil on the U.S. Market: Products, Makers and Brands
How Emtricitabine / Tenofovir Disoproxil appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
25 companies list 49 Emtricitabine / Tenofovir Disoproxil product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2004. Brand names in the directory today include Truvada and Emtricitabine/TDF; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated (11) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Emtricitabine / Tenofovir Disoproxil Is Used (Medicaid Data)
How many Emtricitabine / Tenofovir Disoproxil prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Emtricitabine / Tenofovir Disoproxil prescribed? Of the 1,682 medications we measure, Emtricitabine / Tenofovir Disoproxil ranks #304 by Medicaid prescriptions — more than 82% of them.
Utilization by Emtricitabine / Tenofovir Disoproxil product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet Most dispensed
11 of 93 listed NDCs had Medicaid claims. RxNorm 476556
emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet
1 of 14 listed NDCs had Medicaid claims. RxNorm 1744001
Other Emtricitabine / Tenofovir Disoproxil products: packs and listings not matched to one strength and form
3 of 9 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 15 of the 116 listed Emtricitabine / Tenofovir Disoproxil NDCs had Medicaid claims.
Compare Emtricitabine / Tenofovir Disoproxil Products
A representative set of FDA-listed product records for Emtricitabine / Tenofovir Disoproxil — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| EMTRICITABINE 133 mg/1; TENOFOVIR DISOPROXIL FUMARATE 200 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| EMTRICITABINE 167 mg/1; TENOFOVIR DISOPROXIL FUMARATE 250 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EMTRICITABINE 133 mg/1; TENOFOVIR DISOPROXIL FUMARATE 200 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EMTRICITABINE 167 mg/1; TENOFOVIR DISOPROXIL FUMARATE 250 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | AvKARE | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Cipla USA Inc. × 2 listings | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | DirectRx | ANDA | View NDC → |
| TENOFOVIR DISOPROXIL FUMARATE 300 mg/1; EMTRICITABINE 200 mg | Oral | Direct_Rx | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Oral | Gilead Sciences, Inc | NDA | View NDC → |
| EMTRICITABINE 133 mg/1; TENOFOVIR DISOPROXIL FUMARATE 200 mg | Oral | Gilead Sciences, Inc | NDA | View NDC → |
| EMTRICITABINE 167 mg/1; TENOFOVIR DISOPROXIL FUMARATE 250 mg | Oral | Gilead Sciences, Inc | NDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Gilead Sciences, Inc | NDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Laurus Labs Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | NuCare Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | NuCare Pharmaceuticals,Inc. | NDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Quallent Pharmaceuticals Health Llc | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Strides Pharma Inc. | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| EMTRICITABINE 133 mg/1; TENOFOVIR DISOPROXIL FUMARATE 200 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| EMTRICITABINE 167 mg/1; TENOFOVIR DISOPROXIL FUMARATE 250 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| EMTRICITABINE 133 mg/1; TENOFOVIR DISOPROXIL FUMARATE 200 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| EMTRICITABINE 167 mg/1; TENOFOVIR DISOPROXIL FUMARATE 250 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
Showing 49 of 49 products — FDA National Drug Code Directory. See every product, package size and price: browse all 49 Emtricitabine / Tenofovir Disoproxil NDCs →
Emtricitabine / Tenofovir Disoproxil Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Emtricitabine / Tenofovir Disoproxil — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Emtricitabine / Tenofovir Disoproxil in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Emtricitabine / Tenofovir Disoproxil FDA Approval History
How Emtricitabine / Tenofovir Disoproxil went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Emtricitabine / Tenofovir Disoproxil Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Emtricitabine / Tenofovir Disoproxil recalls since July 2021.
✅No Emtricitabine / Tenofovir Disoproxil recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Emtricitabine / Tenofovir Disoproxil in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 4
- Forms in current FDA listings
- 1 of 1
RxCUI 1008145 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 540395Its 4 strengths (SCD)
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Emtricitabine / Tenofovir Disoproxil Supply and Shortage Status
Whether Emtricitabine / Tenofovir Disoproxil is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Emtricitabine / Tenofovir Disoproxil Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Emtricitabine / Tenofovir Disoproxil: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.
At this strength, Truvada costs pharmacies $59.59 per tablet.
For the generic EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg tablet, pharmacies paid an average of $0.512 per tablet as of Nov 18, 2026, down 6% from $0.544 a year earlier. At this strength, Truvada costs pharmacies $59.59 per tablet.
- What pharmacies pay now
- $0.512
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 2.8%
- from $0.526 on Oct 21, 2026
- Last 12 months
- Down 6%
- from $0.544 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.426 to $0.615
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.512 |
| Oct 2026 | $0.526 |
| Sep 2026 | $0.529 |
| Aug 2026 | $0.505 |
| Jul 2026 | $0.476 |
| Jun 2026 | $0.457 |
| May 2026 | $0.451 |
| Apr 2026 | $0.453 |
| Mar 2026 | $0.457 |
| Feb 2026 | $0.476 |
| Jan 2026 | $0.488 |
| Dec 2025 | $0.524 |
| Nov 2025 | $0.544 |
| Oct 2025 | $0.579 |
| Sep 2025 | $0.587 |
| Aug 2025 | $0.590 |
| Jul 2025 | $0.578 |
| Jun 2025 | $0.585 |
| May 2025 | $0.602 |
| Apr 2025 | $0.605 |
| Mar 2025 | $0.603 |
| Feb 2025 | $0.569 |
| Jan 2025 | $0.526 |
| Dec 2024 | $0.523 |
| Nov 2024 | $0.445 |
| Oct 2024 | $0.600 |
| Sep 2024 | $0.559 |
| Aug 2024 | $0.602 |
| Jul 2024 | $0.455 |
| Jun 2024 | $0.585 |
| May 2024 | $0.426 |
| Apr 2024 | $0.455 |
| Mar 2024 | $0.537 |
| Feb 2024 | $0.593 |
| Jan 2024 | $0.579 |
| Dec 2023 | $0.552 |
| Nov 2023 | $0.615 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg | Generic | $9.36 per tablet | NDC details & price history |
| Tablet · Oral | EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Generic | $0.512 per tablet | NDC details & price history |
| Tablet · Oral | EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg | Truvada (brand) | $59.59 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Emtricitabine / Tenofovir Disoproxil Brand Names
Emtricitabine / Tenofovir Disoproxil has 2 brand names on record: Truvada and Emtricitabine/TDF. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Emtricitabine / Tenofovir Disoproxil: Manufacturers and Labelers
25 companies list Emtricitabine / Tenofovir Disoproxil products with the FDA. By number of product records, the largest are Amneal Pharmaceuticals NY LLC, Aurobindo Pharma Limited, Gilead Sciences, Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 1 more on the FDA NDC directory.
Sources for This Emtricitabine / Tenofovir Disoproxil Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. NuCare Pharmaceuticals,Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →